SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

Dr. Juan Manuel Pérez - 16 April, 2026 0

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

Dr. Omar Tupayachi - 14 April, 2026 0

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Dr. Juan Manuel Pérez - 10 April, 2026 0

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

Noticias Institucionales

Call For Science SOLACI & SBHCI 2026 – Submit Your Work!

solaci - 15 April, 2026 0

We invite you to submit scientific papers and challenging clinical cases for the SOLACI & SBHCI 2026 Congress, taking place from July 29 to...

Watch again “Ultrasound Pulses + Calcium = Coronary Lithotripsy” | SOLACI Technicians Webinar

solaci - 15 April, 2026 0

The webinar “Ultrasound Pulses + Calcium = Coronary Lithotripsy”, held on March 24, 2026 via the Zoom platform, is now available for viewing on...

SOLACI invites you to the 5th International Conference on Clinical and Interventional Cardiology in the Dominican Republic

solaci - 6 April, 2026 0

The Latin American Society of Interventional Cardiology (SOLACI) invites the community to the 5th International Conference on Clinical and Interventional Cardiology (Coronary and Structural),...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad

Tag: acute myocardial infarction

Ischemic and Bleeding Risk After Primary Angioplasty

NCDR ACTION Registry: Anticoagulated Patients with No Higher Risk of Bleeding...

Though on the Rise, the Transradial Approach to Primary PCI Remains...

TCT 2017 | REDUCE: 3 vs 12 Months of Dual Antiplatelet...

CULPRIT-SHOCK Results Will Transform Guidelines and Clinical Practice

DETO2X-AMI: Supplemental O2 Provides No Benefit for Patients with Suspected Infarction

CANTOS: Anti-inflammatory Drug Canakinumab Seems to Reduce CV Events

MRS vs. DES: Which one is associated with better long-term quality...

Prior assistance with Impella 2.5 lowers 30-day mortality in cardiogenic shock due...

CTO in patients with acute myocardial infarction increases long term mortality